A new study published yesterday has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.

Led by Professor Catharine West, REQUITE's co-ordinator, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours.  The study paves the way for better treatment of prostate cancer. To read the newsitem on  AAAS and EurekAlert! click here.

The paper Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer is published in eBiomedicine. EBioMedicine is the leading open access forum for connecting basic and clinical biomedical researchers. The journal is published in collaboration with Cell Press and The Lancet. Abstract